Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NightWare Randomized Trial 02

NCT: NCT04040387 · COMPLETED

NCT IDNCT04040387
StatusCOMPLETED
Start Date2019-07-24
Completion2025-08-02

Brief Summary

This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.

Frequently Asked Questions

What is NightWare Randomized Trial 02?

NightWare Randomized Trial 02 is a clinical trial registered under NCT04040387. Current status: COMPLETED.

What is the status of NCT04040387?

The current status of NCT04040387 (NightWare Randomized Trial 02) is: COMPLETED.

When did NightWare Randomized Trial 02 start?

NightWare Randomized Trial 02 started on 2019-07-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.